Paris Vascular Insights

The PVI Course 2026 programme is now live and this year, we're heading somewhere extraordinary! ✨

Inspired by the spirit of winter adventure, Course brings together an exceptional gathering of internationally renowned experts in a setting that matches their calibre. ❄️

Three days of world-class science, real-case complexity, and the kind of honest, high-energy exchange you simply can't get from a screen.

From complex aortic pathologies to challenging BTK disease and limb salvage, AV fistulae, venous cases, next-generation imaging, and live controversies. Every session is built to stretch your thinking and sharpen your practice.

Start planning your adventure! 💫 🔗 https://brnw.ch/21x36Ct

c-EVAR imaging: CBCT meets CO2 🎥

Prof. Antonello discusses c-EVAR imaging and a potential shift in intra-operative assessment.

Adding CO₂ contrast to Cone-Beam CT may help bridge this diagnostic gap, raising the question of whether conventional post-operative angio-CT could eventually be reduced or avoided.

🖇️ https://brnw.ch/21x346b

Dr. Lobato and Dr. Chong discuss DCBs in BTK disease, with insights from the RANGER trial. 🎥

Despite broad use above the knee, BTK adoption remains limited due to reimbursement and debate.

Key points include low-dose coatings, wound healing, amputation-free survival, and safety data from paclitaxel studies and SWEDEPAD.

Watch now ➡️ https://brnw.ch/21x2ZhT

AVFs, stenosis, thrombosis... What really works, and what doesn’t?

This session reviews endovascular and percutaneous AVFs, their limits, and where evidence still falls short. It also highlights next-gen solutions, including a biological graft and practical strategies for complex access failure.

🖇️ https://brnw.ch/21x2Xaj

A 56-year-old man presents with 24 hours of rest pain on the right side, raising concern for acute limb ischemia. 🦵

CTA shows a common femoral artery occlusion with diffuse femoropopliteal and infragenicular disease. 🩻

→ High-risk profile, complex anatomy, and no obvious path forward. ⚠️

How would you get through? 🤔 https://brnw.ch/21x2UbH

The preliminary program for ATLAS x PVI Aortic 2026 is now available!

Here's a taste of what's in store:

🔸 My masterpieces and endo-nightmares of the year: real cases, real lessons
🔸 The unicorn devices I wish I had: a candid look at what the industry should build next
🔸 Making everyday cases simpler: practical tips and tricks you can use immediately
🔸 Stump the keynote speaker: a challenging case competition you won't want to miss
🔸 Clash of the Titans: a head-to-head debate between two keynote legends
🔸 Setting priorities: a deep dive into the data we actually need to make decisions in aortic surgery

All of this, plus industry showcase and a welcome reception, designed to connect you with the best minds in aortic surgery. 💫

👤 Course directors: Dr. Sukgu Han, Prof. Bernardo Mendes, Prof. Ali Azizzadeh and Prof. Stéphan Haulon.

Browse program ➡️ https://brnw.ch/21x2PZ5

And join us! ➡️ https://brnw.ch/21x2PZ6

6 voices. 1 hashtag. Your crew is ready 🎙️

We are thrilled to introduce the incredible team that will bring you exclusive coverage of PVI Course 2026 :

👉🏼 Diego Ruiz Chiriboga
👉🏼 Marta Lobato
👉🏼 Athanasios Saratzis
👉🏼 Gustavo Aurélio Basso
👉🏼 Mafalda Massara
👉🏼 Edoardo Pasqui

Six experts. One mission: keep you connected, informed, and inspired, all year long. 👀

They'll be all over your feed with the official hashtag : breaking news, hot takes on sessions, behind-the-scenes moments, and everything in between. No filter. Just expertise. 🚀

🌟 Oh, and one more thing! They'll be hosting a special session at PVI Course and going behind the mic with exclusive interviews of scientific committee members throughout the year. Stay tuned!

Meet the crew ➡️ https://brnw.ch/21x2E6N

Evidence spotlight 💡

Intermittent claudication: are we over-treating?

A multi-institutional study validates SVS criteria, showing many IC revascularisations may be inappropriate and associated with worse outcomes.

Treat less, gain more? ➡️ https://brnw.ch/21x2vBr

ISR management: debulking plus DCB in complex femoropopliteal disease 🔍

Prof. Korosoglou presents a two-centre study showing that a debulking-first strategy with DCB achieves high success and durable 12-month patency (79.2%) in complex femoropopliteal ISR.
👉🏼 https://brnw.ch/21x2roA

Behind every great course, there's an extraordinary team. ⭐️
Year after year, our Co-Course Directors bring together the sharpest minds, the boldest debates, and a programme that always delivers what vascular surgery needs most.

👉🏼 Alexandros Mallios
👉🏼 Jorinde Van Laanen
👉🏼 Haimanot (Monnie) Wasse
👉🏼 Sarah Thomis

Four perspectives. One shared mission: make PVI Course 2026 unmissable.

And behind the hands-on experience? 🛠️

Learning by doing has always been at the heart of PVI Course. Once again, our two leading experts are at the helm of the hands-on sessions as Hands-on Directors, bringing you closer to practice, sharpening your skills, and turning knowledge into real-world expertise.

👉🏼 Isabelle Van Herzeele
👉🏼 Adrien Hertault

Meet the full committee ➡️ https://brnw.ch/21x2qpV

Register for PVI Course 2026 ➡️ https://brnw.ch/21x2qpU